An observational study in Ischemic Stroke and Thrombolysis, sponsored by Sigmund Freud PrivatUniversitat. Recruiting at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-16.
Sponsored by Sigmund Freud PrivatUniversitat · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Ischemic Stroke with a site in Austria — 12 open to participants now, 15 under way, 1 of them phase 3. Ischemic Stroke · Austria.
Among the 49 studies in Ischemic Stroke with a site in Austria, this one is the 11th largest by planned enrollment of the 12 observational ones that give a count, is one of 4 that started in 2026, is one of 12 observational ones, reaches primary completion later than 9 of the 14 other live ones, and was the 46th registered.
2,629 studies on the registry are indexed under Ischemic Stroke; 983 are open to participants now.
Browse Ischemic Stroke studies →12 of the 49 studies in Ischemic Stroke with a site in Austria are open now. Recruiting first, the newest first:
Sigmund Freud PrivatUniversitat · Sites in Austria, Germany, Switzerland
Ages 18+
MED-EL Elektromedizinische Geräte GesmbH · Sites in Austria
Ages 18–99
VASCage GmbH · Sites in Austria
Ages 18+
Insel Gruppe AG, University Hospital Bern · Sites in Austria, Belgium, Canada and 9 more countries
Ages 18+
Insel Gruppe AG, University Hospital Bern · Sites in Austria, Belgium, Canada and 12 more countries
Ages 18+
A study can be open while its sites in Austria have not opened yet or have stopped. Only those recruiting at a site in Austria →
Of the 668 Ischemic Stroke studies recruiting now, 403 (60%) set no upper age limit and 62 (9%) stop at 75 or younger; 27 take children under 18; 41 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 10 · Phase 3 10 · Phase 4 5
First in 2000; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is below the median of 300 across 776 observational studies indexed under Ischemic Stroke.
Median enrollment 447 across the 34 interventional studies, 1,000 across the 12 observational. Of the 32 that completed or were terminated, 12 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
30 of 49 have an industry lead sponsor. The 10 most frequent:
Sigmund Freud PrivatUniversitat is the lead sponsor of 12 studies on the registry; 10 are open to participants now.
Sigmund Freud PrivatUniversitat has 2 studies filed under Ischemic Stroke — fewer than ten, so there is no comparison to draw.
4 of the studies in Ischemic Stroke with a site in Austria that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07511868VASCage GmbHDigital Application for Stroke Health | 2026-12-31 |
| NCT07299994Sigmund Freud PrivatUniversitatEfficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease | 2026-12-31 |
| NCT04582825VASCage GmbHStroke-Card Registry | 2027-03-31 |
| NCT07299981Sigmund Freud PrivatUniversitatQuantitative Net Water Uptake as a Predictor of Functional Outcomes After Intravenous Thrombolysis in Acute Ischemic Stroke International Multicenter Observational Retrospective Study | 2027-04-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 49 studies in Ischemic Stroke with a site in Austria, from their registry updates:
This tab as a report to print or save as PDF → With an account.
While the effectiveness of intravenous thrombolysis (IVT) decreases over time, patients show considerable variability in how quickly their ischemic core progresses. Quantitative net water uptake (NWU) has emerged as a biomarker indicating blood-brain barrier disruption and may better reflect the "tissue clock" than time alone. Low NWU is associated with favorable outcomes, whereas high NWU predicts poor outcomes and futile recanalization. The study aims to determine whether NWU measured on initial non-contrast CT is a treatment effect modifier for the IVT therapy.
Patients aged over 18 years with acute ischemic stroke, symptom onset within 24 hours prior to admission and treatment in one of the stroke units of the participating institutions between 2018 and 2025 treated using IVT and fullfilling inclusion criteria
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: No Interventions
Not applicable as this is an observational, retrospective study.
Number of participants with functional independence (modified Rankin Scale score 0-1)
Functional independence defined as a modified Rankin Scale (mRS) score of 0-1 assessed at 90 days.
Time frame: at 90 days
Number of participants with symptomatic intracerebral hemorrhage
Symptomatic intracerebral hemorrhage (sICH) as defined by the European Cooperative Acute Stroke Study (ECASS) III criteria (i.e., an ICH associated with an increase of ≥4 points on the NIHSS or death where intracranial hemorrhage is the predominant cause of neurological deterioration).
Time frame: at 24 hours
Number of participants with intracerebral hemorrhage on follow-up brain imaging
Intracerebral hemorrhage detected on follow-up brain imaging performed within 24 hours after treatment.
Time frame: at 24 hours
Mortality
Time frame: at 90 days
Plan to share: Yes — Individual participant data that underlie the results after deidentification
Supporting information: Study protocol, Statistical analysis plan
Access criteria: Data that support the findings of this study will be available from the corresponding author after academic board review and upon reasonable request
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Apr 2027, 14 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sigmund Freud PrivatUniversitat